Find participating medical centers and current study status in each of them
Find participating medical centers
-
Home
-
Clinical Study Finder
- ENSEMBLE
Study to Evaluate the Effectiveness and Safety of Ocrelizumab in Participants With Early Stage Relapsing Remitting Multiple Sclerosis (RRMS)
Autoimmune Disorder Multiple Sclerosis (MS) Relapsing-Remitting Multiple Sclerosis (RRMS)
Study results
LPS MA30143 ENSEMBLE Final Results September 2023 English
(PDF, 0.3 MB)
LPS MA30143 ENSEMBLE Final Results September 2023 Canada French
(PDF, 0.3 MB)
LPS MA30143 ENSEMBLE Final Results September 2023 Netherlands Dutch
(PDF, 0.8 MB)
LPS MA30143 ENSEMBLE Final Results September 2023 Brazil Portuguese
(PDF, 0.4 MB)
LPS MA30143 ENSEMBLE Final Results September 2023 Spain Spanish
(PDF, 0.7 MB)
LPS MA30143 ENSEMBLE Final Results September 2023 Slovakia Slovak
(PDF, 0.7 MB)
LPS MA30143 ENSEMBLE Final Results September 2023 Denmark Danish
(PDF, 1.3 MB)
LPS MA30143 ENSEMBLE Final Results September 2023 France French
(PDF, 0.3 MB)
LPS MA30143 ENSEMBLE Final Results September 2023 LA Spanish
(PDF, 0.2 MB)
LPS MA30143 ENSEMBLE Final Results September 2023 Mexico Spanish
(PDF, 0.3 MB)
LPS MA30143 ENSEMBLE Final Results September 2023 Turkey Turkish
(PDF, 1.6 MB)
LPS MA30143 ENSEMBLE Final Results September 2023 Slovenia Slovenian
(PDF, 0.7 MB)
LPS MA30143 ENSEMBLE Final Results September 2023 Italy Italian
(PDF, 0.6 MB)
LPS MA30143 ENSEMBLE Final Results September 2023 German Germany
(PDF, 0.7 MB)
LPS MA30143 ENSEMBLE Final Results September 2023 Romania Romanian
(PDF, 0.6 MB)
LPS MA30143 ENSEMBLE Final Results November 2023 Portugal Portuguese
(PDF, 0.5 MB)
Explore related studies
For the latest version of this information please go to www.forpatients.roche.com